Business

Cipla, Pulmatrix join hands to co-develop asthma drug

Cipla, Pulmatrix join hands to co-develop asthma drug Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma, it added.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts